My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

    Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, Stevens MJ, Feldman EL; DCCT/EDIC Research Group.

    Diabetes Care. 2006 Feb;29(2):340-4.PMID: 16443884 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

    White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.

    J Pediatr. 2001 Dec;139(6):804-12.PMID: 11743505 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.

    White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, Hubbard LD, Lachin JM, Nathan DM.

    Arch Ophthalmol. 2008 Dec;126(12):1707-15.PMID: 19064853 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

    [No authors listed]

    Diabetes Care. 1999 Jan;22(1):99-111.PMID: 10333910 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.

    Genuth S.

    Endocr Pract. 2006 Jan-Feb;12 Suppl 1:34-41. Review.PMID: 16627378 [PubMed - indexed for MEDLINE]Related articles

    6.

    Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    JAMA. 2003 Oct 22;290(16):2159-67.PMID: 14570951 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    JAMA. 2002 May 15;287(19):2563-9.PMID: 12020338 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.

    [No authors listed]

    Diabetes. 1996 Oct;45(10):1289-98.PMID: 8826962 [PubMed - indexed for MEDLINE]Related articles

    9.

    Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    [No authors listed]

    N Engl J Med. 2000 Feb 10;342(6):381-9. Erratum in: N Engl J Med 2000 May 4;342(18):1376. PMID: 10666428 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

    Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM; DCCT/EDIC Research Group.

    Diabetes. 2006 Dec;55(12):3556-65.PMID: 17130504 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).

    Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, Sommer C, Cleary PA, Lachin JM, Herman WH; DCCT/EDIC Research Group.

    Circulation. 2009 Jun 9;119(22):2886-93. Epub 2009 May 26.PMID: 19470886 [PubMed - in process]Related articles

    12.

    The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group.

    [No authors listed]

    Ann Intern Med. 1995 Apr 15;122(8):561-8.PMID: 7887548 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.

    Van Den Eeden SK, Sarma AV, Rutledge BN, Cleary PA, Kusek JW, Nyberg LM, McVary KT, Wessells H; Diabetes Control and Complications Trial/Epidemiology of Diabetes Research Group.

    Diabetes Care. 2009 Apr;32(4):664-70. Epub 2009 Jan 26.PMID: 19171725 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

    [No authors listed]

    Diabetes. 1997 Nov;46(11):1829-39.PMID: 9356033 [PubMed - indexed for MEDLINE]Related articles

    15.

    Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?

    Albers JW, Herman WH, Pop-Busui R, Martin CL, Cleary P, Waberski B; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Intervention and Complications (EDIC) Research Group.

    Diabetes Care. 2007 Oct;30(10):2613-8. Epub 2007 Jul 20.PMID: 17644617 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

    [No authors listed]

    Diabetes. 1995 Aug;44(8):968-83.PMID: 7622004 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.

    [No authors listed]

    Ann Intern Med. 1998 Apr 1;128(7):517-23.PMID: 9518395 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group.

    [No authors listed]

    N Engl J Med. 1993 Sep 30;329(14):977-86.PMID: 8366922 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT).

    [No authors listed]

    Diabetologia. 1998 Apr;41(4):416-23.PMID: 9562345 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study.

    Wake N, Hisashige A, Katayama T, Kishikawa H, Ohkubo Y, Sakai M, Araki E, Shichiri M.

    Diabetes Res Clin Pract. 2000 Jun;48(3):201-10.PMID: 10802159 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity